General Diligence. Licensee will use Commercially Reasonable Efforts to actively develop, obtain Regulatory Approval and commercialize at least one Licensed Product in each Indication within the Field of Use.
Appears in 3 contracts
Samples: Research, Collaboration & License Agreement (Passage BIO, Inc.), Research, Collaboration & License Agreement (Passage BIO, Inc.), Research, Collaboration & License Agreement (Passage BIO, Inc.)
General Diligence. Licensee will use Commercially Reasonable Efforts to actively clinically develop, obtain Regulatory Approval and commercialize at least one Licensed Product in each Indication of the three (3) Subfields within the Field of Usein the Major Markets.
Appears in 3 contracts
Samples: Research, Collaboration & License Agreement (Ultragenyx Pharmaceutical Inc.), Research, Collaboration & License Agreement (Dimension Therapeutics, Inc.), Research, Collaboration & License Agreement (Dimension Therapeutics, Inc.)
General Diligence. Licensee will use Commercially Reasonable Efforts to actively clinically develop, obtain Regulatory Approval and commercialize at least one (1) Product for each Licensed Product in each Indication within the Field of Useselected by Licensee pursuant to Section 2.7 (“General Diligence”).
Appears in 3 contracts
Samples: Collaboration & License Agreement, Collaboration & License Agreement (BioNTech SE), Collaboration & License Agreement (BioNTech SE)
